The Waveform Fluctuation and the Clinical Factors of the Initial and Sustained Erythropoietic Response to Continuous Erythropoietin Receptor Activator in Hemodialysis Patients

Objectives. Erythropoiesis-stimulating agents (ESA) are the main treatment for anemia in hemodialysis (HD) patients. We evaluated factors determining the response after treatment of a new ESA (continuous erythropoietin erythropoietin receptor activator (CERA)). Methods. 61 HD patients were classifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wen-Sheng, Wu, Yueh-Lin, Li, Szu-Yuan, Yang, Wu-Chang, Chen, Tzen-Wen, Lin, Chih-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific World Journal 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349104/
https://www.ncbi.nlm.nih.gov/pubmed/22619601
http://dx.doi.org/10.1100/2012/157437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349104/
https://www.ncbi.nlm.nih.gov/pubmed/22619601
http://dx.doi.org/10.1100/2012/157437

Ejemplares similares